WallStreetZenWallStreetZen

NASDAQ: AARD
Aardvark Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Aardvark Therapeutics revenue was $0.00 for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, AARD annual revenue was $0.0, with N/A growth year-over-year.

AARD revenue history

Current Revenue
$0.0
Current Earnings
-$20.6M
Current Profit Margin
0%

Be the first to know when AARD announces revenue.

AARD Revenue History By Year

AARD Yearly RevenueAARD RevenueAARD ChangeAARD Revenue Growth
2024-12-31$0.00N/AN/A
2023-12-31$0.00N/AN/A
2022-12-31$0.00N/AN/A

1 of 1

Aardvark Therapeutics Revenue FAQ

What was AARD's revenue last quarter?

Aardvark Therapeutics (NASDAQ: AARD) reported Q4 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Aardvark Therapeutics's revenue was $0.00.

What was Aardvark Therapeutics's revenue in 2024?

Aardvark Therapeutics's annual revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.

How much does Aardvark Therapeutics make in a day?

Based on Aardvark Therapeutics annual revenue for the past two years, AARD makes an average of $0.00 per day.

What was Aardvark Therapeutics's annual revenue growth in the past year?

As of Q2 2025, Aardvark Therapeutics's revenue has grown null year over year. Aardvark Therapeutics's revenue in the past year totaled $0.00.

How much does Aardvark Therapeutics make in a year?

Aardvark Therapeutics's revenue by year for the past two years is:
  • Aardvark Therapeutics's revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.
  • Aardvark Therapeutics's annual revenue for Dec 31, 2023 was $0.00, a N/A decrease from 2022.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.